Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

GlaxoSmithKline and UCL to develop biologic

March 24, 2009 Research and Development GSK

Researchers at University College London are to work with GlaxoSmithKline to develop a new treatment for the rare and often …
News

Merck Serono sets up biotech fund

March 24, 2009 Research and Development Merck Serono, biotech

Merck Serono has set up a venture capital fund to invest in emerging biotech companies working in its core therapy …
News

Biosimilars: time for an approval pathway in the US

March 23, 2009 Research and Development, Sales and Marketing US, generics

Congress has received another bill seeking to establish a biosimilars approval pathway in the US. HR 1427 represents the latest …
News

Bayer strikes R&D deal with Chinese university

March 20, 2009 Research and Development Bayer, China, academic research

 Bayer has furthered its R&D expansion in China with an agreement to form a joint pharmaceutical research centre with Tsinghua …
News

Shire withdraws ADHD patch filing

March 19, 2009 Research and Development, Sales and Marketing Shire

Shire has withdrawn the European marketing application for its Attention Deficit Hyperactivity Disorder (ADHD) patch product Daytrana. The product's active …
News

Sanofi boosted by Multaq vote of approval

March 19, 2009 Research and Development, Sales and Marketing FDA, Multaq, Sanofi, US

An FDA committee has recommended Sanofi-Aventis' new atrial fibrillation treatment Multaq, the company's most important late-stage drug. The FDA cardiovascular …
News

FDA to review Xarelto safety concerns

March 19, 2009 Research and Development, Sales and Marketing Xarelto

Anti-blood clotting drug Xarelto could fail to win approval in the US due to safety concerns. The FDA has convened …
News

Biosimilars bill offers 12 years’ marketing exclusivity

March 19, 2009 Research and Development US, generics

The US moved one step closer to creating a market for biosimilars – substitutable versions of branded biologic drugs – …
News

Hamburg appointed as new FDA head

March 18, 2009 Research and Development FDA

A leading public health expert has been appointed as the new head of the FDA. President Obama has selected Dr …
News

Patent office shows tougher stance on “evergreening”

March 18, 2009 Research and Development Europe

The rate of patent applications refused in Europe has risen to an all time high, as authorities target "evergreening" of …
News

Getting the most out of your product portfolio

March 17, 2009 Research and Development, Sales and Marketing portfolio, product

Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …
Feature

One in five European biotech companies facing bankruptcy

March 17, 2009 Research and Development biotech

Around one in five European biotech companies could go bust by the end of 2009 if new funding doesn't emerge …
News

Blow for Genzyme as FDA finds fault with Allston facility

March 13, 2009 Research and Development, Sales and Marketing FDA, Genzyme

The chances of approval for Genzyme's new Pompe disease drug Lumizyme have diminished dramatically after the US Food and Drug …
News

Working Life: Andrew Clark

March 13, 2009 Research and Development, Sales and Marketing UCB, library

How did you find your way into your current role? On return from a working holiday to New Zealand I …
Feature

Government picks top-level NHS-academic research centres

March 12, 2009 Research and Development Academic

Five establishments have been named by the government as Academic Health Science Centres (AHSCs). The centres – UCL Partners, Cambridge …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026